Whilst it may modestly increase endogenous GLP-1 levels, the effect is much smaller and more transient than pharmacological GLP-1 receptor agonists such as semaglutide or liraglutide, which are evidence-based treatments recommended by NICE for type 2 diabetes management
MontanoLoza, Yu Jun Wong Liver International .2026;[Epub] CrossRef A Simple Clinical Prediction Model for Metabolic Dysfunction-Associated Steatotic Liver Disease in Adolescents with Obesity Yang Liao, Fei Wang, Ting-Ting Tian, Xiu-Fen Li Indian Journal of Pediatrics .2026;[Epub] CrossRef Esteatosis heptica metablica en el sndrome cardio-reno-metablico: la H silenciada Javier Crespo, Paula Iruzubieta, Tomas de Vega, Jose Luis Calleja Medicina Clnica .2026
Retatrutide is an investigational triple agonist designed to activate three metabolic receptors at once: GLP-1, GIP, and glucagon
Noom is a leading app-based platform for weight loss coaching, though it does not provide GLP-1 medications
Bull World Health Organ 2004 Nov
This is metabolic education done right
